IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics—Brief Report
OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)—the target allergen of delayed anaphylaxis to red meat—is associated with corona...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 38; no. 7; pp. 1665 - 1669 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.07.2018
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
ISSN | 1079-5642 1524-4636 1524-4636 |
DOI | 10.1161/ATVBAHA.118.311222 |
Cover
Abstract | OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)—the target allergen of delayed anaphylaxis to red meat—is associated with coronary artery disease.
APPROACH AND RESULTS—Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal–specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal–specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02).
CONCLUSIONS—Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal—an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis. |
---|---|
AbstractList | Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)-the target allergen of delayed anaphylaxis to red meat-is associated with coronary artery disease.OBJECTIVEEmerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)-the target allergen of delayed anaphylaxis to red meat-is associated with coronary artery disease.Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal-specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal-specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02).APPROACH AND RESULTSTotal IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal-specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal-specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02).Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal-an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis.CONCLUSIONSIncreased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal-an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis. Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)-the target allergen of delayed anaphylaxis to red meat-is associated with coronary artery disease. Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects ( =0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger ( <0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal-specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal-specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; =0.02). Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal-an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis. OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal)—the target allergen of delayed anaphylaxis to red meat—is associated with coronary artery disease. APPROACH AND RESULTS—Total IgE and specific IgE to α-Gal were assayed on sera from 118 subjects who presented for cardiac catheterization and underwent intravascular ultrasound. IgE to α-Gal was detected in 26%, and atheroma burden was higher in sensitized subjects (P=0.02). Because α-Gal sensitization relates to an environmental exposure that could be a risk factor for early-onset coronary artery disease (ie, tick bites), we age stratified the cohort. In subjects ≤65 years of age, the strength of the association with atheroma burden was stronger (P<0.001), and plaques in the sensitized group had less stable features based on intravascular ultrasound. To address the specificity of the association with IgE to α-Gal, IgE to inhalants and peanut were assayed and were not associated with coronary artery disease. Total IgE and α-Gal–specific IgE were strongly associated with each other, but the strength of the relationship with atheroma burden was stronger for α-Gal–specific IgE. This association was significant when adjusted for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02). CONCLUSIONS—Increased atheroma burden and plaques with more unstable features were associated with IgE to α-Gal—an effect most pronounced in subjects ≤65 years of age. IgE sensitization to α-Gal may represent a novel, and potentially modifiable, risk factor for coronary atherosclerosis. Supplemental Digital Content is available in the text. |
Author | Nguyen, Anh T. Taylor, Angela M. Platts-Mills, Thomas A.E. Schuyler, Alexander J. McNamara, Coleen A. Commins, Scott P. Wilson, Jeffrey M. |
AuthorAffiliation | From the Division of Allergy and Immunology (J.M.W., A.J.S., T.A.E.P.-M.) Division of Cardiology, Robert M. Berne Cardiovascular Center (A.T.N., A.M.T., C.A.M.), University of Virginia, Charlottesville Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill (S.P.C.) |
AuthorAffiliation_xml | – name: From the Division of Allergy and Immunology (J.M.W., A.J.S., T.A.E.P.-M.) Division of Cardiology, Robert M. Berne Cardiovascular Center (A.T.N., A.M.T., C.A.M.), University of Virginia, Charlottesville Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill (S.P.C.) |
Author_xml | – sequence: 1 givenname: Jeffrey surname: Wilson middlename: M. fullname: Wilson, Jeffrey M. organization: From the Division of Allergy and Immunology (J.M.W., A.J.S., T.A.E.P.-M.) Division of Cardiology, Robert M. Berne Cardiovascular Center (A.T.N., A.M.T., C.A.M.), University of Virginia, Charlottesville Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill (S.P.C.) – sequence: 2 givenname: Anh surname: Nguyen middlename: T. fullname: Nguyen, Anh T. – sequence: 3 givenname: Alexander surname: Schuyler middlename: J. fullname: Schuyler, Alexander J. – sequence: 4 givenname: Scott surname: Commins middlename: P. fullname: Commins, Scott P. – sequence: 5 givenname: Angela surname: Taylor middlename: M. fullname: Taylor, Angela M. – sequence: 6 givenname: Thomas surname: Platts-Mills middlename: A.E. fullname: Platts-Mills, Thomas A.E. – sequence: 7 givenname: Coleen surname: McNamara middlename: A. fullname: McNamara, Coleen A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29903734$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ustu1DAUjVARfcAPsEBesiDFrzjJBikdlXakoiLUlmV0x7mZGJy4tT1U7PgIfoEP4Ef4CL4Ej2YYAQsWln3sc8711T2H2d7kJsyyp4weM6bYy-bq5qQ5bxKojgVjnPMH2QEruMylEmovnWlZ54WSfD87DOEDpVRyTh9l-7yuqSiFPMi-zZenJDoSByRvYBzBGpjIpTVLF0DrAbzpkJyBBR1dwPzH95y9EPnugswDaUJw2kDEjrw3cSDzSXuEkGCTbL0bgdw4uxqRwNSRtxbuVhg21OspRFhYJLNUKTmiNyEaHX5--XriDfbkHd46Hx9nD3uwAZ9s96Ps-vXp1ew8v7g8m8-ai1wLldougQvR933Jy6KSXYW9QomoesXqBcgCCya6vuh5haVWmheSYi1BLDSqolIgjrJXG9_b1WLETuMUPdj21psR_OfWgWn_fpnM0C7dp1ZRUUtaJIPnWwPv1l3GdjRBo7UwoVuFltNCibpijCbqsz9r7Yr8nk0i8A1BexeCx35HYbRdB6DdBiCBqt0EIImqf0TaRIjGrf9r7P-lciO9dzYNIny0q3v07YBg49CuwyMULXJOWUXLBPO0uBS_AMMuyaY |
CitedBy_id | crossref_primary_10_1111_all_16187 crossref_primary_10_1016_j_jaci_2020_01_047 crossref_primary_10_14309_ajg_0000000000002219 crossref_primary_10_1007_s11882_019_0835_9 crossref_primary_10_1007_s11894_022_00860_7 crossref_primary_10_1111_all_16381 crossref_primary_10_1080_23744235_2022_2057584 crossref_primary_10_1093_cvr_cvab285 crossref_primary_10_1111_aen_12480 crossref_primary_10_1073_pnas_2123212119 crossref_primary_10_1111_all_13873 crossref_primary_10_2147_ITT_S276872 crossref_primary_10_1016_j_jaci_2018_10_029 crossref_primary_10_1016_j_jaip_2024_06_035 crossref_primary_10_1016_j_aller_2019_07_004 crossref_primary_10_1111_all_14802 crossref_primary_10_1038_s41598_025_93031_3 crossref_primary_10_1016_j_jaip_2023_10_046 crossref_primary_10_1111_cea_13695 crossref_primary_10_1152_physrev_00041_2023 crossref_primary_10_1016_j_biopha_2023_115829 crossref_primary_10_1016_j_jaad_2023_04_054 crossref_primary_10_1016_j_athoracsur_2020_07_050 crossref_primary_10_1042_BCJ20200915 crossref_primary_10_1007_s40521_024_00371_y crossref_primary_10_1111_pai_13854 crossref_primary_10_1007_s40267_023_01005_0 crossref_primary_10_1016_j_anai_2022_07_002 crossref_primary_10_1161_ATVBAHA_120_314735 crossref_primary_10_1053_j_jvca_2024_07_035 crossref_primary_10_1161_ATVBAHA_120_313609 crossref_primary_10_1161_ATVBAHA_120_313608 crossref_primary_10_1097_MOP_0000000000000955 crossref_primary_10_3389_falgy_2024_1488857 crossref_primary_10_1111_all_15426 crossref_primary_10_18632_aging_101894 crossref_primary_10_3389_falgy_2023_1270326 crossref_primary_10_3389_fcimb_2021_680264 crossref_primary_10_3389_fcvm_2021_791028 crossref_primary_10_4049_jimmunol_2100712 crossref_primary_10_1111_cea_13683 crossref_primary_10_1016_j_cgh_2022_12_035 crossref_primary_10_1161_ATVBAHA_119_312001 crossref_primary_10_3389_fcvm_2022_864602 crossref_primary_10_3389_falgy_2021_783279 crossref_primary_10_1111_all_15230 crossref_primary_10_3389_fimmu_2024_1335911 crossref_primary_10_1016_j_numecd_2024_103833 crossref_primary_10_3390_molecules28145452 crossref_primary_10_1016_j_anai_2019_11_024 crossref_primary_10_1016_j_anai_2019_03_021 crossref_primary_10_1111_all_16003 crossref_primary_10_1186_s12979_022_00316_6 crossref_primary_10_1080_1744666X_2025_2475984 crossref_primary_10_1002_chem_202500050 crossref_primary_10_1111_aen_12420 crossref_primary_10_3389_falgy_2025_1535103 crossref_primary_10_1007_s12016_024_08981_9 crossref_primary_10_1111_all_16529 crossref_primary_10_1097_ACI_0000000000000523 crossref_primary_10_1097_TP_0000000000003408 crossref_primary_10_3389_fped_2021_801753 crossref_primary_10_1016_j_anai_2024_01_029 crossref_primary_10_1016_j_biopha_2018_11_142 crossref_primary_10_1161_ATVBAHA_121_316878 crossref_primary_10_3389_fimmu_2019_01210 crossref_primary_10_1016_j_jaci_2020_02_012 crossref_primary_10_1016_j_jaci_2023_09_038 crossref_primary_10_1055_a_1870_7328 crossref_primary_10_1161_ATVBAHA_118_311999 crossref_primary_10_7759_cureus_24551 crossref_primary_10_1007_s40257_022_00696_x crossref_primary_10_1016_j_jaip_2019_09_017 crossref_primary_10_1007_s12350_018_01506_w crossref_primary_10_1016_j_jtcvs_2021_03_100 |
Cites_doi | 10.1016/j.atherosclerosis.2016.05.045 10.1038/nm1601 10.1172/JCI46028 10.1126/science.117.3045.505 10.1016/j.jaci.2014.01.024 10.1056/NEJMoa074943 10.1161/CIRCRESAHA.117.306044 10.1371/journal.pone.0090222 10.1016/S0735-1097(01)01175-5 10.1007/s11882-017-0672-7 10.1016/S0368-1319(69)80071-2 10.1084/jem.160.5.1519 10.1016/j.alit.2015.10.001 10.1111/all.13156 10.1016/j.jaci.2008.10.052 10.1016/j.jaci.2011.02.019 10.1038/ni.2001 10.1371/journal.pone.0055566 10.1016/j.jim.2005.12.003 |
ContentType | Journal Article |
Copyright | 2018 American Heart Association, Inc. 2018 American Heart Association, Inc. 2018 |
Copyright_xml | – notice: 2018 American Heart Association, Inc. – notice: 2018 American Heart Association, Inc. 2018 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1161/ATVBAHA.118.311222 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4636 |
EndPage | 1669 |
ExternalDocumentID | PMC6039405 29903734 10_1161_ATVBAHA_118_311222 00043605-201807000-00024 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R37 AI020565 – fundername: NHLBI NIH HHS grantid: R01 HL107490 – fundername: NIAID NIH HHS grantid: R01 AI020565 – fundername: NHLBI NIH HHS grantid: K23 HL093118 – fundername: NHLBI NIH HHS grantid: P01 HL055798 – fundername: NHLBI NIH HHS grantid: R01 HL136098 – fundername: NHLBI NIH HHS grantid: P01 HL136275 – fundername: NIAID NIH HHS grantid: T32 AI007496 – fundername: NIAID NIH HHS grantid: K08 AI085190 |
GroupedDBID | --- .3C .55 .GJ .Z2 01R 0R~ 1J1 23N 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFS ACGOD ACILI ACLDA ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AGINI AHJKT AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B N~M O9- OAG OAH OB2 OCUKA ODA OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ PZZ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WOQ WOW X3V X3W X7M XXN XYM YFH ZGI ZZMQN AAYXX ADGHP CITATION ACIJW AWKKM NPM OK1 OLW RHF 7X8 ADKSD ADSXY 5PM |
ID | FETCH-LOGICAL-c3624-7a233fff727584d8ef6e4ee6f619ba45e513df5f28e7c6c2540e94a3bce6586a3 |
ISSN | 1079-5642 1524-4636 |
IngestDate | Thu Aug 21 18:30:33 EDT 2025 Mon Sep 08 10:25:19 EDT 2025 Wed Feb 19 02:36:16 EST 2025 Tue Jul 01 02:22:00 EDT 2025 Thu Apr 24 23:02:52 EDT 2025 Fri May 16 03:42:33 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | atherosclerosis galactosyl-(1-3)galactose risk factors immunoglobulin E red meat |
Language | English |
License | 2018 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3624-7a233fff727584d8ef6e4ee6f619ba45e513df5f28e7c6c2540e94a3bce6586a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC6039405 |
PMID | 29903734 |
PQID | 2056398110 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6039405 proquest_miscellaneous_2056398110 pubmed_primary_29903734 crossref_primary_10_1161_ATVBAHA_118_311222 crossref_citationtrail_10_1161_ATVBAHA_118_311222 wolterskluwer_health_00043605-201807000-00024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-July |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-July |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Arteriosclerosis, thrombosis, and vascular biology |
PublicationTitleAlternate | Arterioscler Thromb Vasc Biol |
PublicationYear | 2018 |
Publisher | American Heart Association, Inc Lippincott Williams & Wilkins |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott Williams & Wilkins |
References | e_1_3_5_17_2 Galili U (e_1_3_5_9_2) 2017 e_1_3_5_16_2 e_1_3_5_15_2 e_1_3_5_14_2 e_1_3_5_12_2 e_1_3_5_13_2 e_1_3_5_10_2 e_1_3_5_11_2 e_1_3_5_21_2 e_1_3_5_19_2 e_1_3_5_18_2 e_1_3_5_2_2 e_1_3_5_8_2 e_1_3_5_20_2 e_1_3_5_7_2 e_1_3_5_4_2 e_1_3_5_3_2 e_1_3_5_6_2 e_1_3_5_5_2 |
References_xml | – ident: e_1_3_5_7_2 doi: 10.1016/j.atherosclerosis.2016.05.045 – ident: e_1_3_5_5_2 doi: 10.1038/nm1601 – ident: e_1_3_5_6_2 doi: 10.1172/JCI46028 – ident: e_1_3_5_4_2 doi: 10.1126/science.117.3045.505 – ident: e_1_3_5_14_2 doi: 10.1016/j.jaci.2014.01.024 – ident: e_1_3_5_10_2 doi: 10.1056/NEJMoa074943 – ident: e_1_3_5_19_2 doi: 10.1161/CIRCRESAHA.117.306044 – ident: e_1_3_5_16_2 doi: 10.1371/journal.pone.0090222 – ident: e_1_3_5_15_2 doi: 10.1016/S0735-1097(01)01175-5 – ident: e_1_3_5_21_2 doi: 10.1007/s11882-017-0672-7 – ident: e_1_3_5_3_2 doi: 10.1016/S0368-1319(69)80071-2 – ident: e_1_3_5_8_2 doi: 10.1084/jem.160.5.1519 – ident: e_1_3_5_13_2 doi: 10.1016/j.alit.2015.10.001 – ident: e_1_3_5_17_2 doi: 10.1111/all.13156 – ident: e_1_3_5_11_2 doi: 10.1016/j.jaci.2008.10.052 – ident: e_1_3_5_12_2 doi: 10.1016/j.jaci.2011.02.019 – ident: e_1_3_5_2_2 doi: 10.1038/ni.2001 – volume-title: The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine. year: 2017 ident: e_1_3_5_9_2 – ident: e_1_3_5_18_2 doi: 10.1371/journal.pone.0055566 – ident: e_1_3_5_20_2 doi: 10.1016/j.jim.2005.12.003 |
SSID | ssj0004220 |
Score | 2.5102737 |
Snippet | OBJECTIVE—Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the... Emerging evidence suggests a link between coronary artery disease and type 2 immunity. We sought to test the hypothesis that IgE sensitization to the mammalian... Supplemental Digital Content is available in the text. |
SourceID | pubmedcentral proquest pubmed crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1665 |
SubjectTerms | Clinical and Population Studies |
Title | IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics—Brief Report |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-201807000-00024 https://www.ncbi.nlm.nih.gov/pubmed/29903734 https://www.proquest.com/docview/2056398110 https://pubmed.ncbi.nlm.nih.gov/PMC6039405 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1djtMwELZ2FwkhIcTPAuVPRmKfiksTJ07y2FZF7aLyo22XfYucxGkr2gaRVmh54hBcgQNwEQ7BSRjHjpu2C2J5iWrHcWvNl5lv3JkxQs9olAS2m3LSTH25dcN8wh1BCfeAjLucJnFxnM_gNeuNnOMz92xv_7AStbRaRo34y4V5Jf8jVegDucos2UtI1kwKHfAZ5AtXkDBc_0nG_XG35I4DPp-rLYs3s-k4y3ks86mmCYCAz-SZOrkgR53uUdsioLs6lJjuej83QgL2-V5uzILWkMHq0GxJgpjNef20UGMquWDGpTVRQ0eSX8r0q85m6ecyisJpgzOeaqJfpcItGUw6zXJYE1hqVepAHtowj8qW_C4TKaurRVX2iXSumM5Fqw8aZmN7vDoXujTCpD40_SfxZHWuMx9NYk_92NyXyTJ6-_2kKFnxtlHdFLF8E0Bb6vGmFxCXqcJdDaF1u-0QWR-tqvypXwG5V9HkFlNnWGhWAM3gYovDpMVpDU_brV4Lmn6DAoW17bV9LWMKtsyuCYYs3DBmhXoOaPihmmMfXbE9r4g-ePWuUgTftlWRDb3GMheMWS92f8cm39pxonZjga9_zmScRv6hSNOokK3hTXRDe0m4pSB_C-2JxW10daDjQO6g74B8vMwwgBMb5OMt5OM18n_-INbzCuZxP8drzGMJZGwwj0vMY4V5DDjBGvNqaIl5vIX5X1-_FWjHCu2HaPSyO-z0iD5whMTA4xzicZvSNE2B0wMvT3yRMuEIwVJmBRF3XOFaNEnd1PaFF7PYBm9HBA6nUSyAyDNO76KDRbYQ9xH2hZ-CtvNcebaV4yZBSi3B4dHYjRzmRjVklWIJY12NXx4KMwv_DIcaqptnPqpaNH8d_bSUdggmQ_4PyBciW-WhDU4PDXwg_jV0T0nfzCfZKfWoU0PeBi7MAFmOfvPOYjopytKzJg3A_ashsoGgUCV0h0XQAWu6RL6vQDRURQvbeXCpVT1E19bv-yN0sPy0Eo_BLVhGT4qX5DcZOgtv |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IgE+to+the+Mammalian+Oligosaccharide+Galactose-%CE%B1-1%2C3-Galactose+Is+Associated+With+Increased+Atheroma+Volume+and+Plaques+With+Unstable+Characteristics%E2%80%94Brief+Report&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Wilson%2C+Jeffrey+M.&rft.au=Nguyen%2C+Anh+T.&rft.au=Schuyler%2C+Alexander+J.&rft.au=Commins%2C+Scott+P.&rft.date=2018-07-01&rft.issn=1079-5642&rft.eissn=1524-4636&rft.volume=38&rft.issue=7&rft.spage=1665&rft.epage=1669&rft_id=info:doi/10.1161%2FATVBAHA.118.311222&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_ATVBAHA_118_311222 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon |